Macy’s: Unfortunate Earnings Delay, but Preliminary Sales Match Expectations
We continue to see Macy’s stock as undervalued.

Key Morningstar Metrics for Macy’s
- Fair Value Estimate: $25.00
- Morningstar Rating: 4 stars
- Morningstar Economic Moat Rating: None
- Morningstar Uncertainty Rating: Very High
What We Thought of Macy’s Earnings
Macy’s M postponed its third-quarter earnings report to Dec. 11 from Nov. 26 after the firm discovered that its delivery expenses over the past three years had been underreported by $132 million-$152 million. The company claims a former employee intentionally misstated these costs. Although a disappointing development, the problem appears to be contained. The cost discrepancies are immaterial, considering Macy’s annual operating expenses exceed $8 billion.
The firm also provided some preliminary third-quarter results. Although it reported some weakness in cold weather categories (a warm fall) and e-commerce, its comparable sales (company-owned plus licensed) matched our estimate by falling 1.3%. Looking deeper, Macy’s had a 2% same-store sales drop, but there were positive signs, including same-store sales increases of 1.9% at the “First 50″ Macy’s stores and above 3% at Bloomingdale’s and Bluemercury. We regard these results as supportive of the company’s “A Bold New Chapter” plan, as they suggest that improvements in the leading Macy’s stores and a focus on luxury are improving sales.
Further, Macy’s revealed that its asset sales were $66 million and other revenue was at $161 million in the quarter. As our estimates for these items were lower ($19 million and $138 million, respectively), there could be an upside to our breakeven EPS forecast.
Macy’s will provide fourth-quarter guidance when it reports its full results. There was a brief mention in the preliminary release that November comparable sales are trending ahead of those for the third quarter. This could indicate fourth-quarter outperformance is coming, but we think it is too early in the holiday shopping period to draw conclusions. For now, we are not changing our fair value estimate of $25 per share and rate the stock as very undervalued. Macy’s problems are well-known, but we think it has reasonable plans to stabilize its sales and improve margins.
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.
